These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 364006)

  • 21. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Improving the bioavailability of digoxin.
    Binnion PF; Klopp RW
    Lancet; 1975 Jun; 1(7922):1422-3. PubMed ID: 49581
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biologic availability of digoxin in soft gelatin capsules and in tablets].
    Merotti GC; Ghirardi P; Marzo A; Parenti MA
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1612-4. PubMed ID: 4458749
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics and bioavailability of digoxin capsules, solution and tablets after single and multiple doses.
    Lloyd BL; Greenblatt DJ; Allen MD; Harmatz JS; Smith TW
    Am J Cardiol; 1978 Jul; 42(1):129-36. PubMed ID: 677028
    [No Abstract]   [Full Text] [Related]  

  • 25. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioavailability and effect on myocardial function of a solution of digoxin in a soft gelatin capsule].
    Longhini C; Alvisi V; Bagni B; Tralli M; Portaluppi F; Pavani F; Fersini C
    Boll Soc Ital Cardiol; 1976; 21(10):1753-63. PubMed ID: 1031600
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bioavailability of a solution of digoxin in a soft gelatin capsule].
    Marzo A; Ghirardi P; Merotti GC; Gandolfi C
    Boll Soc Ital Cardiol; 1976; 21(10):1781-5. PubMed ID: 1031602
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dietary fiber on the bioavailability of digoxin in capsules.
    Johnson BF; Rodin SM; Hoch K; Shekar V
    J Clin Pharmacol; 1987 Jul; 27(7):487-90. PubMed ID: 2821081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)].
    Flasch H; Asmussen B; Heinz N
    Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of particle size on the bioavailability of digoxin.
    Jounela AJ; Pentikäinen PJ; Sothmann A
    Eur J Clin Pharmacol; 1975 Jun; 8(5):365-70. PubMed ID: 1233237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
    Cohen AF; Kroon R; Schoemaker HC; Breimer DD; Van Vliet-Verbeek A; Brandenburg HC
    Br J Clin Pharmacol; 1993 Feb; 35(2):136-42. PubMed ID: 8443031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bioavailability of digoxin.
    Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037
    [No Abstract]   [Full Text] [Related]  

  • 39. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in the biological availability of digoxin.
    Shaw TR; Howard MR; Hamer J
    Lancet; 1972 Aug; 2(7772):303-7. PubMed ID: 4115034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.